CLINICAL_TRIALS trial_result · 2021-12-21

Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer [Phase 1]

Phase 1 trial evaluating a radiolabeled monoclonal antibody in patients with advanced ovarian epithelial cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ludwig Institute for Cancer Research | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-12-21